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Introduction
According to the seventh report of  the Joint National 
Committee on Prevention, Detection, Evaluation and 
Treatment of  High Blood Pressure (JNC7), “Prehyper-
tension” is defined as a systolic blood pressure (SBP) of  
120-139 mmHg and/or diastolic blood pressure (DBP) 
of  80-89 mmHg in adults aged 18 years or more1. Indi-
viduals with pre-hypertension are at high risk of  develop-
ing clinical hypertension compared to people with lower 
blood pressure (BP) levels. It is related to the morbidity 
and mortality of  cardiovascular disease (CVD)1,2. Identifi-
cation of  individuals with pre-hypertension is an import-
ant strategy to prevent the progression to hypertension 
and, thus, reducing the risk of  CVD in the general pop-
ulation3.
Unlike men, women show an abrupt increase in BP 
around the fifth decade of  life, and by sixth decade, sur-
pass men in the incidence of  primary hypertension4. Re-
searchers have not been able to separate the effects of  sex 
hormones from the effect of  aging on arterial pressure, 
mainly because sex steroid concentrations decrease in hu-
mans as they age3,5.
It has been reported that the prevalence of  pre-hyper-
tension in women is higher than in their male counter-
parts, and they present increased rates of  cardiovascular 
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Abstract
Objectives: We aimed to assess the prevalence of  prehypertension and its associated factors in a population of  Congolese pre 
and postmenopausal women. 
Methods: We had consecutively recruited 200 women (100 premenopausal and 100 postmenopausal) aged 40 – 60 years at the 
department of  Gynecology and Obstetrics, University of  Kinshasa Hospital, and AKRAM Medical Center in Kinshasa, DRC. 
An interview was carried out using a questionnaire that comprised questions related to lifestyle, menses characteristics, medi-
cal history of  diabetes, CVD, hypertension, current antihypertensive medication and use of  traditional medicine. In addition, 
physical examination and biological measurements were performed. Multivariate logistic regression analysis was used to assess 
associated factors with prehypertension. 
Results: Of  the participants, 34% were normotensive, 38.5 % prehypertensive and 27.5% hypertensive. Compared to normal 
blood pressure, prehypertension was common in the older (age>50 years of  age) women. Menopause, the use of  traditional 
medicine and older age were associated with prehypertension. However, only menopause (aOR: 2.71; 95%CI: 1.10-3.52) and 
the use of  traditional medicine (aOR: 2.24; 95% CI: 1.07-4.7) remained associated with prehypertension in a multivariate logistic 
regression analysis. 
Conclusion: This study showed that prehypertension is common among Congolese menopausal women, and that menopause 
and the use of  traditional medicine were the main factors associated with prehypertension.
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disease with advancing age3. Menopausal and perimeno-
pausal periods are critical periods for emergence of  CVD 
because of  change in hormonal pattern6. Women tend 
to pass most of  the part of  their life in the menopaus-
al period and it is estimated that in 2030, 1.2 billion of  
women will be peri- or postmenopausal, and that this to-
tal will increase by 4.7 million a year. Although overall 
number will have increased by 2030, the proportion of  
postmenopausal women living in the industrialized re-
gions will have declined to 24%, and 76% will be living in 
developing countries7. Because of  these predicted chang-
es in population structure, physicians are beginning to 
consider menopause not only as a natural phenomenon 
but also as a major public health problem7. Apart from 
changes in hormonal pattern, environmental factors such 
as exposure to heavy metals and/or non secured herbal 
medicines could contribute to this increased prevalence 
of  Pre-hypertension mainly in the developing World8. 
Hypertension is a major risk factor for cardiovascular 
disease (CVD) in the sub-Saharan African region, as in 
developed countries and there are several reports on the 
high prevalence of  hypertension in some African cities9-12. 
Studies related to the relationship between menopausal 
status and cardiovascular risks, such as pre-hypertension, 
metabolic syndrome, chronic kidney failure are scarce13-17. 
On the other hand, most studies related to pre-hyperten-
sion were conducted in other population than menopaus-
al women, such as adolescents18 and the general popula-
tion19-23. To the best of  our best knowledge, there have 
been no reported studies on pre-hypertension and its 
relationship with menopausal status neither in the Dem-
ocratic Republic of  the Congo (DRC), nor in any other 
sub-Saharan African country.
Given the public health burden of  menopause, we aimed 
to assess the rate of  pre-hypertension and associated fac-
tors in a population of  Congolese post-menopausal and 
pre-menopausal women.
Methods
1. Participants and study design
A cross-sectional study was conducted from January 
through June 2010 at the Department of  Gynecology 
and Obstetrics, University of  Kinshasa Hospital, and 
AKRAM Medical Center in Kinshasa, DRC. A total of  
200 women aged 40 - 60 years participated in the study.
A convenience sampling procedure by consecutive and 
stratified recruitment was used to select subjects. Details 
of  the methods were published in our previous report17. 
Briefly, an interview was conducted; information regard-
ing lifestyle (self-reported physical activity, alcohol con-
sumption and smoking habit), menses characteristics, 
duration of  menopause, family and past medical history 
of  diabetes, CVD, hypertension, current antihypertensive 
medication and use of  traditional medicine was collected.
A physical examination was performed; adiposity was 
estimated with the use of  body mass index (BMI) and 
waist circumference (WC). Seated blood pressure (BP) 
was measured on the left arm from each subject with the 
use of  Omron M1 digital electronic blood pressure/pulse 
monitor (OMRON Corporation, Tokyo) after five min-
utes of  relaxation; average of  3 BP measurements were 
used for analysis. Combur test was used to assess dipstick 
proteinuria. Biological measurements were performed af-
ter 12h fasting (total cholesterol, high density lipoprotein, 
cholesterol, triglycerides, and glucose; low density lipo-
protein was calculated.
2. Definition of  Pre-hypertension and menopause
Pre-hypertension was defined according to JNC71. BP 
measurements and self-reported high BP or hyperten-
sion, use of  antihypertensive drugs at baseline were used 
to classify subjects as having normal BP, pre-hyperten-
sion, or hypertension. Normal BP was defined as SBP< 
120 mm Hg and DBP< 80 mm Hg. Pre-hypertension was 
defined as SBP 120 to 139 mm Hg and/or DBP 80 to 89 
mm Hg. Hypertension was defined as SBP ≥ 140 mm Hg 
and/or DBP ≥ 90 mm Hg or by the use of  antihyperten-
sive medications.
Women were defined as post-menopausal if  they report-
ed their last menses to be at least 12 months prior to this 
study, and pre-menopausal if  they had had an unchanged 
or irregular menstrual pattern24.
3. Ethical consideration
Each participant provided a written informed consent 
and the study was approved by the Research Ethics com-
mittee of  the faculty of  Medicine, University of  Kinsha-
sa.
4. Statistical analysis
Data was expressed as relative frequency using percent-
ages. Chi square was performed to compare normally 
distributed categorical variables. Multivariate logistic re-
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gression analysis was performed to evaluate the relative 
contribution of  menopause to the risk of  pre-hyperten-
sion after adjusting for other covariates (age, and edu-
cation level, BMI, smoking, alcohol intake, duration of  
menopause).
As it is known that menopause is related to age, we first 
check if  there is interaction between the two variables. 
The interaction term was not significant, then we put 
both of  them in the regression model; P value < 0.05 
defined the statistical significance. All statistical analyses 
were performed with STATA SE, 10.1(Statacorp, TX, 
USA).
Results
Of  the 200 pre and post-menopausal women who par-
ticipated in this study, 34% were normotensive, 38.5 % 
were pre-hypertensive and the remaining 27.5% were hy-
pertensive. Compared to normal blood pressure, pre-hy-
pertension was more common in the older age group 
(age>50 years; p=0.03).
According to the menses status, when we divide the study 
group in to pre and post-menopausalwomen; post-meno-
pausal women were more likely to be pre-hypertensive 
(p=0.03) and inversely, pre-menopausal women were 
normotensive (p=0.04) (table1)
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Table 1. Baseline socio-demographic characteristics of the study  
population according to BP characterization. 
  






























Married,% 62(91.18) 67(87.01) 48(87.27) 
Education,% 51(75) 61(79.22) 43(78.18) 
  
Abbreviations: BP, blood pressure, yrs, years, %, percent. 
*, P < 0.05 comparing pre-hypertension and normal BP; Data are expressed as relative frequency in percent. 
In contrast, no statistically significant differences were 
found between the above mentioned groups of  women 
when considering others cardiovascular risk factors such 
as smoking, alcohol intake, family history of  diabetes, 
family history of  CVD, family history of  hypertension, 
large waist circumference, lipid alterations, high glucose 
level, less physical activity and proteinuria (p>0.05), as 
shown in Tables 2 and 3.
Table 2. Associated clinical cardiovascular risk factors according to BP characterization. 
 






FH-DM, % 10(14.71) 18(23.38) 14(25.45) 
FH-HT, %        24(35.29) 37(48.05) 33(60) 
FH-CVD,% - 1(1.3) 3(5.45) 
Alcohol intake,% 14(20.59) 16(20.78) 8(14.55) 
Smoking,% 1(1.47) - - 
Use of traditional 
medicine,% 
20(29.41) 12(15.58) 16(29.09) 

















Waist > 88cm 26(38.24) 42(54.55) 30(54.55) 
Abbreviations: BP, blood pressure, BMI, body mass index, FH-CVD, family history of cardiovascular disease, FH-
DM, family history of diabetes mellitus, FH-HT, family history of hypertension, yrs, years, %, percent, Phys, 
physical. 
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Table 3. Associated biological cardiovascular risk factors according to BP characterization. 
 






TC >200 mg/dl 31(45.59) 43(55.84) 33(60) 
LDL-c≥130 mg/dl  55(81) 65(84) 48(87) 
HDL-c < 50 mg/dl  19(27.94) 21(27.27) 11(20) 
TG ≥ 150 mg/dl  8(11.76) 18(23.38) 9(16.36) 
Proteinuria, % 24(35.29) 36(48) 21(38.89) 
Glucose≥126 mg/dl  5(7.35) 8(10.39) 6(9.5) 
 
Abbreviations: BP, blood pressure; HDL-c, high-density lipoprotein-cholesterol; LDL-c, low-density lipoprotein-
cholesterol; TC, total cholesterol; TG, triglycerides; %, percent.  
Data are expressed as relative frequency in percent. traditional medicine and older age (age > 50 years) were 
associated with pre-hypertension. However, after adjust-
ment in a multivariate logistic regression analysis, only 
menopause (aOR: 2.71; 95%CI: 1.10-3.52) and use of  the 
traditional medicine (aOR: 2.24; 95% CI: 1.07-4.7) were 
found to be associated with hypertension. (Table 4).
In addition, the proportion of  obese women was relative-
ly higher among pre-hypertensive women as compared 
with normotensive ones; however, the level of  signifi-
cance of  the difference was borderline (p=0.05) (Table 
2). Furthermore, before adjustment, menopause, use of  
 
Table 4. Risk factors associated with pre-hypertension: 
Multivariate logistic regression analysis. 
 
Prehypertension OR 95%CI aOR 95%CI 
Menopause 2.25 1.25-4.05 2.71 1.10-3.52 
Use of traditional 
medicine 
2.24 1.08-4.65 2.24 1.07-4.7 
Age > 50 years 1.97 1.11-3.52 2.85 0.89-9.03 
 
Logistic regression variables: menopause, use of traditional medicine, age > 50 years, LDL-c ≥ 130 mg/dl, family 
history of DM, Family history of HT, education (> 12 years), alcohol intake, smoking, married, proteinuria, family 
history of CVD, BMI, physical activity, waist > 88 cm, TC > 200 m/dl, HDL< 50 mg/dl. 
Discussion
To determine the prevalence of  pre-hypertension and its 
associated risk factors in Congolese pre and post-meno-
pausal women was the aim of  this study. To our knowl-
edge, this is the first study that assessed pre-hypertension 
in a specified group of  menopausal sub-Saharan African 
women.
Findings are depicted as follows: first, more than one 
third of  the study population had pre-hypertension and 
the proportion of  pre-hypertensive women was higher as 
compared with normotensive and hypertensive women; 
second, pre-hypertensive women were older than normo-
tensive ones; third, menopause and the use of  traditional 
medicine were the main independent risk factors associ-
ated with pre-hypertension.    
The prevalence of  pre-hypertension observed in our 
sample of  menopausal women, 38.5%, is close to 32.1% 
found in black American women aged 50 -79 years 
by Hsia25 in the Women Health Initiative study and in 
Sub-Saharan African countries. Agyemang et al23 report-
ed a prevalence rate of  35% in Ghana and, in Ethiopia, 
Mengitsu19 reported a rate of  37.2%; however, the pop-
ulation of  women used in those studies were younger 
(from 18 years of  age) than ours (40 - 60 years). This 
situation suggests that the prevalence of  pre-hyperten-
sion in our sample of  Congolese menopausal women is 
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somewhat high. This prevalence is obviously lower than 
43.1% found byAllal-Elasmi et al in Tunisian women 
aged 35 - 69 years21. Inversely, Isezuo et al22 in Nigeria 
and Nuwaha et al20 in Uganda have reported 23.6% and 
29.4%, respectively. 
These results are also different from ours, mainly because 
of  the difference in age of  the studied population.
In our study, twenty four percent of  post-menopausal 
women were pre-hypertensive, which is relatively close to 
27.3% found in USA for Hispanic post-menopausal wom-
en25. The population used in this study is ethnically differ-
ent from Congolese women who took part in our study. 
The high prevalence of  prehypertension in our sample 
might be attributed to the fact that menopausal women 
experience the change in hormonal pattern through the 
reduction of  estrogen levels which contributes to a rise in 
BP through the activation of  the renin-angiotensin sys-
tem and the sympathetic nervous system26. In addition, 
the loss of  estrogen can also lead to hypertension by 
upregulation of  endothelin levels, a vasoconstrictor that 
augments sodium reabsorption by renal tubules27.
Pre-hypertension affects more than one third of  the 
study population; this supports the view that, the rate of  
chronic non communicable diseases in developing coun-
tries is approaching the rates in the developed countries20.
In the present study, compared to normotensive meno-
pausal women, pre-hypertensive women were older. The 
relationship between age and the occurrence of  elevat-
ed blood pressure is well documented in the literature. 
Indeed, the prevalence and incidence of  elevated BP in-
crease with increasing age. Data from the National Health 
and Nutrition Examination Survey (NHANES) showed 
that the prevalence of  high blood pressure rose signifi-
cantly with age; from 2.7% in women aged 20-34 years to 
18.4% in women aged 40-44 years28. On the other hand, 
aging is the primary risk factor for hypertension in meno-
pausal women and it is likely to be caused in part by the 
falling estrogen levels during this period29.
Pre-hypertensive women were more obese than normo-
tensive ones but the difference was borderline (p=0.05). 
These results are different from findings in previous stud-
ies in which a significant association was found between 
obesity and pre-hypertension23. This difference could 
be attributable to the relatively small sample size. In our 
study, however, menopause and the use of  traditional 
medicine were the main predictors of  pre-hypertension.
The influence of  menopause on blood pressure is diffi-
cult to evaluate because menopause coincides with ag-
ing29. Some studies have reported a strong association 
between blood pressure and menopause. Compared to 
others risk factor of  cardiovascular disease in women; 
menopause appears to be the strongest one28. In other 
previous studies, no such strong association between 
menopause and blood pressure was found30-32. The use 
of  traditional medicine appears as another determinant 
of  pre-hypertension in this sample of  Congolese meno-
pausal women.
In developing countries, uses of  traditional medicine for 
primary health care may be an important risk for the de-
velopment of  kidney injury because of  several factors: 
non-conventional preparations, unknown exact biological 
activity, unknown dosage, toxicity, interactions33. Herbal 
solutions are not regulated as Western medicine.
Kidneys injury caused by traditional medicine consist of  
different renal manifestations such as hypertension, acute 
tubular necrosis, acute interstitial nephritis, papillary ne-
crosis, kidney stones, urinary retention, chronic tubule 
interstitial nephritis with fibrosis33. Herbal preparations 
can be contaminated by heavy metals and/or pesticide34. 
Since hypertension is a common pathway of  renal dis-
ease, it is hard to distinguish whether it as a cause or a 
consequence. In DRC, the prevalence of  hypertension 
increases from 10 to 28% within two decades, same for 
renal failure and only 8% of  the population can beneft 
from hemodialysis because of  its high cost and unavail-
ability of  the service35. Thus, managing different risk fac-




The present study has some limitations. The cross-sec-
tional design of  our study and the small sample size limits 
the generalization of  its findings to all Congolese meno-
pausal women. Further studies should be conducted in 
order to eventually establish the relationship between the 
use of  traditional medicine and the occurrence of  pre-hy-
pertension in Congolese women during menopause.
Another limitation is that neither the nature nor the indi-
cation of  the traditional medicine was identified. Identifi-
cation of  those products could be helpful to prevent such 
adverse outcomes.
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Renal function were not assessed in this study, only pro-
teinuria; which is quite not enough; to know exactly what 
is the effect of  traditional medicine on the kidneys, fur-
ther study should assess renal function.
The diet, one of  the important factors of  the occur-
rence of  high blood pressure has not been assessed in 
this study; for better assessment of  high blood pressure , 
further study should also focus in the diet.
In addition, as reported in our previous paper, meno-
pause was defined on the basis of  self-reported menstru-
al bleeding characteristics without hormone measure-
ments17.
In conclusion, this study has shown that pre-hypertension 
is common in Congolese menopausal women. Meno-
pause and use of  traditional medicine were the main in-
dependent factors associated with pre-hypertension.
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